뒤로
Onconetix Inc (ONCO) 주가 예측
ONCO 주가 차트
ONCO 주가 예측
Onconetix Inc
$1.87
25.85%
$0.38
종가: Apr 01, 16:00:00 GMT-4
$1.79
-4.54%
$-0.08
애프터마켓: Apr 01, 20:00:00 GMT-4
주요 통계
이전 종가
$1.49
시가
$1.5
일일 범위
$1.25 - $1.92
52주 범위
$1.17 - $74.37
거래량
2.5M
평균 거래량
1.3M
배당수익률
--
EPS(TTM)
-342.64
시가총액
$2.7M
ONCO란 무엇인가요?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.